17.09.2020 • News

Henkel Hikes US Sanitizer Output

Germany’s Henkel has announced plans to invest $23 million to expand its range of Dial liquid hand soap and hand sanitizers in the US. The company will install new equipment and carry out a series of improvements that will increase production at its sites in Geneva, New York and West Hazleton, Pennsylvania.

An investment of $17.3 million will be made in Geneva on new equipment and technology to support production of Dial hand sanitizers and foaming hand wash, while $2.5 million will be spent at West Hazleton. As part of the overall project, Henkel has also spent $3 million on extra equipment to support on-site production at both sites.

Some aspects of the new technology will be installed in October and operational in November 2020, and the remainder will be up and running by June 2021.

To also support the expansion at Geneva, which will contribute 45-55% of the plant’s total production, Henkel will create 180 new jobs. In addition, the company will rebrand the Geneva facility, which it acquired in 2018 from Zotos Professional, to reflect the expansion of its operations beyond haircare products.

 

Author: Elaine Burridge, Freelance Journalist

Germany’s Henkel will invest $23 million to expand its range of Dial liquid...
Germany’s Henkel will invest $23 million to expand its range of Dial liquid hand soap and hand sanitizers in the US. The company will install new equipment and carry out improvements that will raise production at in Geneva, New York, and West Hazleton, Pennsylvania. (c) Henkel

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.